Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-25T06:33:02.763Z Has data issue: false hasContentIssue false
  • English
  • Français

Acute Blocking of Naloxone-Precipitated Opiate Withdrawal Symptoms by Methohexitone

Published online by Cambridge University Press:  02 January 2018

N. Loimer ,
R. Schmid ,
K. Lenz ,
O. Presslich  and
J. Grünberger
N. Loimer*
Affiliation:
Intensive Care Unit, Psychiatric University Clinic of Vienna, Währinger Gürtel 18–20, A-1090 Vienna, Austria
R. Schmid
Affiliation:
Laboratory of Psychoactive Drug Analysis, Psychiatric University Clinic of Vienna
K. Lenz
Affiliation:
Intensive Care Unit, Medical University of Vienna
O. Presslich
Affiliation:
Intensive Care Unit, Psychiatric University Clinic of Vienna
J. Grünberger
Affiliation:
Psychodiagnostic Unit, Psychiatric University Clinic of Vienna
*
∗Correspondence
Get access Rights & Permissions [Opens in a new window]

Abstract

In a double-blind placebo-controlled trial of 18 patients, methohexitone blocked objective signs of opiate withdrawal caused by a bolus injection of naloxone. Furthermore, in continuing the naloxone therapy for 48 hours, no withdrawal signs appeared. Levels of withdrawal distress returned to normal levels within six days. This approach can be regarded as an effective and well tolerated withdrawal therapy with low drop-out rates.

Type
Brief Reports
Information
The British Journal of Psychiatry , Volume 157 , Issue 5 , November 1990 , pp. 748 - 752
Copyright
Copyright © The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM–III–R). Washington, DC: APA.Google Scholar
Brewer, C., Rezae, H. & Blailey, C. (1988) Opioid withdrawal and naltrexone induction in 48–72 hours with minimal dropout, using a modification of naltrexone-clonidine technique. British Journal of Psychiatry, 153, 340–343.Google Scholar
Charney, D. S., Heinger, G. R. & Kleber, H. D. (1986) The combined use of clonidine and naltrexone as rapid, safe and effective treatment of abrupt withdrawal from methadone. American Journal of Psychiatry, 143, 7.Google ScholarPubMed
Eisenberg, R. M. (1985) Effects of chronic treatment with diazepam, phenobarbital or amphetamine on naloxone-precipitated morphine withdrawal. Drug and Alcohol Dependence, 15, 175–181.CrossRefGoogle ScholarPubMed
Gold, M. S. & Kleber, H. D. (1979) A rationale for opiate withdrawal symptomatology. Drug and Alcohol Dependence, 4, 419–424.Google Scholar
Gossop, M., Bradly, B. & Phillips, G. T. (1987) An investigation of withdrawal symptoms shown by opiate addicts during and subsequent to a 21–day in-patient methadone detoxification procedure. Addict Behaviour, 12, 1–6.Google Scholar
Hendrie, C. A. (1985) Opiate dependence and withdrawal – a new synthesis? Pharmacology Biochemistry & Behavior, 23, 863–870.Google Scholar
Kleber, H. D. & Riordan, C. E. (1982) The treatment of narcotic withdrawal: a historical review. Journal of Clinical Psychiatry, 43, 30–34.Google Scholar
Kolb, L. & Himmelsbach, C. K. (1938) Clinical studies of drug addiction, III. American Journal of Psychiatry, 94, 759–799.CrossRefGoogle Scholar
Loimer, N., Schmid, R., Presslich, O., et al (1988) Naloxone treatment to overcome opiate withdrawal syndrome. British Journal of Psychiatry, 153, 851–852.Google Scholar
Resnick, R. B., Kestenbaum, R. S., Washton, A., et al (1977) Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone. Clinical Pharmacology and Therapeutics, 21, 4.Google Scholar
Vlissides, D. N., Jenner, F. A. & Liappas, I. A. (1988) The use of naloxone during the withdrawal syndrome from heroin. British Journal of Psychiatry, 152, 565–567.Google Scholar
Wang, R. I. H., Wiesen, R. L., Lamid, S., et al (1974) Rating the presence and severity of opiate dependence. Clinical Pharmacology and Therapeutics, 16, 653–658.Google Scholar
Wikler, A., Fraser, H. F. & Isbell, H. (1953) Nallylnormorphine: effects of single doses and precipitation of acute ‘abstinence syndromes’ during addiction to morphine, methadone or heroin in man (post-addicts). Journal of Pharmacology and Experimental Therapeutics, 109, 8–20.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.